CITIGROUP INC - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 33 filers reported holding SPRING BK PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$5,000
-77.3%
1,562
-73.7%
0.00%
Q2 2019$22,000
-45.0%
5,935
+57.8%
0.00%
Q1 2019$40,000
-2.4%
3,761
-4.6%
0.00%
Q4 2018$41,000
-10.9%
3,942
+2.0%
0.00%
Q3 2018$46,000
+206.7%
3,863
+213.6%
0.00%
Q2 2018$15,0001,2320.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders